Recording of patient-reported outcomes (PROs) enables direct measurement of the experiences of patients with cancer. In the past decade, the use of PROs has become a …
The last 5 years have witnessed relevant advances in the systemic treatment of hepatocellular carcinoma. New data have emerged since the development of the EASL …
M Bolliger, JA Kroehnert, F Molineus, D Kandioler… - European Surgery, 2018 - Springer
Summary Background The standardized Clavien-Dindo classification of surgical complications is applied as a simple and widely used tool to assess and report …
MC Garassino, S Gadgeel, E Esteban, E Felip… - The Lancet …, 2020 - thelancet.com
Background Pembrolizumab plus pemetrexed–platinum led to superior overall survival and progression-free survival, and a higher proportion of patients with a confirmed complete or …
MM Hudson, MJ Ehrhardt, N Bhakta, M Baassiri… - … , biomarkers & prevention, 2017 - AACR
Abstract Characterization of toxicity associated with cancer and its treatment is essential to quantify risk, inform optimization of therapeutic approaches for newly diagnosed patients …
As smartphones and consumer wearable devices become more ubiquitous, there is a growing opportunity to capture rich mobile sensor data continuously, passively, and in real …
F Scotté, P Bossi, E Carola, T Cudennec… - Annals of …, 2018 - Elsevier
Around 60% of people living with cancer are aged 65 years or older. Older cancer patients face a unique set of age-associated changes, comorbidities and circumstances that impact …
Objectives In our systematic review, we assessed past and current practice of patient- reported outcome (PRO) measurement in cancer randomized, controlled trials (RCTs) …
G Thanarajasingam, LM Minasian, F Baron… - The Lancet …, 2018 - thelancet.com
Tremendous progress in treatment and outcomes has been achieved across the whole range of haematological malignancies in the past two decades. Although cure rates for …